vivoslife.com - רווח לפני ניכוי ריבית, מסים, בלאי ופחת VVOS

This EBITDA chart demonstrates the financial trajectory of Vivos Therapeutics (VVOS), where 0.00 is the current value of the indicator. Revenues are based on the sale of systems for the non-surgical correction of jaw pathologies and the treatment of apnea. Prospects rely on creating a healthy sleep environment through the training of dentists. Stability is guaranteed by partnerships with dental laboratories while maintaining full patent ownership.

The use of external contract laboratories and partner distribution for apnea treatment directly determines the operating expense structure of Vivos Therapeutics (VVOS). This metric measures net cash flow from core operations before depreciation, allowing for an assessment of the business's real-time daily efficiency; therefore, analyzing the company's consolidated EBITDA helps investors avoid freezing capital when purchasing the asset at local yield peaks.